Tagged / disease

Funding Opportunity – Roadmaps to human biology-based disease research

Call Outline:

To support strategic scientific dialogue around the concept of extending the vision of “21st century toxicology” to the wider biosciences, Humane Society International and The Humane Society of the United States are offering grants of up to $10,000 (USD) in funding to support the development and open-access publication of in-depth, independent review articles in discrete areas of human disease/biomedicine by health scientists with relevant expertise.

Who can apply

• Health researchers holding a PhD (or equivalent) degree and be able to demonstrate relevant experience in the disease area they propose to review.
• Eligible individuals may currently be employed in a health research position in the academic, private or public sectors, or may have retired from such a position.
• Applications will be accepted from single authors or groups.
• The current call is restricted to applicants in the United States, Canada, European Union and South Korea.

The closing date for this call is 30 June 2017

If you are interested in applying to this or other non-UK funded calls, please contact Emily Cieciura, RKEO’s Research Facilitator: EU & International.

 

Funding opportunities : Biomedical catalyst

theme - health

UK businesses can apply for a share of up to £10 million to develop innovative ideas that will help solve healthcare challenges. The project must be carried out in the UK.  Projects must be led by a micro, small or medium business enterprise (SME) with companies applying either individually or in collaboration with other SME businesses or research organisations. See more information on academic led applications.

The aim of this competition is to develop innovative healthcare technologies and processes that will help provide:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

This competition has 2 awards:

Application deadline is midday Wednesday 29 March.

Feasibility studies award

Total project costs of up to £200,000. Projects should last between 3 months and 1 year. Projects must start by 1 August 2017 and end by 1 August 2018.

Primer award

Projects are likely to range in size from total project costs of £200,000 to £1.5 million. Projects should last up to 2 years. Projects must start by 1 August 2017 and end by 1 August 2019.

The Biomedical Catalyst supports innovative solutions to healthcare challenges. Innovate UK, the Medical Research Council and Scottish Enterprise fund Biomedical Catalyst awards.

If you are interested in submitting to to this call you must contact your  RKEO Funding Development Officer with adequate notice before the deadline.

For more funding opportunities that are most relevant to you, you can set up your own personalised alerts on Research Professional. If you need help setting these up, just ask your School’s/Faculty’s Funding Development Officer in  RKEO or view the recent blog post here.

If thinking of applying, why not add notification of your interest on Research Professional’s record of the bid so that BU colleagues can see your intention to bid and contact you to collaborate.